← Open Payments lookup

SARAH SMITH: Open Payments

NPI 1700404951 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$310 in 13 payments from 10 companies in 2025. Trend: 2023 $616 · 2024 $342 · 2025 $310

Food & beverage: $310
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP2$55
Daiichi Sankyo Inc.2$52
ABBVIE INC.2$40
Novartis Pharmaceuticals Corporation1$35
E.R. Squibb & Sons, L.L.C.1$29
Bayer Healthcare Pharmaceuticals Inc.1$25
Merck Sharp & Dohme LLC1$22
Immunocore Limited1$21
Incyte Corporation1$16
Regeneron Healthcare Solutions, Inc.1$15

Products named: IMFINZI, CREON, PLUVICTO, OPDIVO, Enhertu, Xofigo, DATROWAY, KEYTRUDA.

Industry payments across TX — which companies pay providers there.